BAILARD, INC. - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 127 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$89,276
-57.1%
14,216
-27.8%
0.00%
-66.7%
Q3 2022$208,000
+62.5%
19,700
-16.2%
0.01%
+80.0%
Q2 2022$128,000
-39.0%
23,500
+167.0%
0.01%
-28.6%
Q3 2021$210,0008,8000.01%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 544,196$5,741,00019.52%
Elmwood Wealth Management, Inc. 2,364,240$24,943,00012.45%
72 Investment Holdings, LLC 474,067$5,001,0003.96%
PFM Health Sciences, LP 6,000,000$63,300,0002.29%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 257,892$2,716,0000.87%
Avidity Partners Management LP 3,172,600$33,471,0000.68%
Rokos Capital Management LLP 1,907,509$20,811,0000.62%
Green Alpha Advisors, LLC 69,376$732,0000.62%
Nelson Capital Management, LLC 85,020$897,0000.26%
Tekla Capital Management LLC 567,147$5,983,0000.24%
View complete list of CARIBOU BIOSCIENCES INC shareholders